Collegium Pharmaceutical is a specialty pharmaceutical company focusing on the development of proprietary, late-stage products, addressing non-medical use and abuse of prescription drugs, and providing extended-release delivery through its patent-protected DETERx formulation platform. Founded in 2002, the company aims to build a portfolio of products for the treatment of chronic pain that possess tamper-resistant features.
Collegium Pharmaceutical is headquartered in Massachusetts and employs 266 individuals. The company is led by CEO Joseph J. Ciaffoni and has established itself as a great place to work, ranking number one on Zippia's list of Best Companies to Work for in Stoughton, MA. With an annual revenue of $310 million, Collegium continues to innovate and make strides in the pharmaceutical industry.
